These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1539199

  • 1. Posttransplant renal allograft dysfunction as a prognostic factor in triple therapy-treated patients.
    Pallardó LM, García J, Sánchez J, Górriz JL, Orero E, Calabuig F.
    Transplant Proc; 1992 Feb; 24(1):113-4. PubMed ID: 1539199
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Triple drug maintenance therapy in renal transplantation.
    Pallardó LM, Sánchez J, Hernandez M, Górriz JL, Sánchez P, Beneyto I, Rochera A.
    Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
    Griñó JM, Castelao AM, Serón D, Gonzalez C, Galceran JM, Gil-Vernet S, Andrés E, Bover J, Torras J, Alsina J.
    Transplant Proc; 1992 Feb; 24(1):39-41. PubMed ID: 1539329
    [No Abstract] [Full Text] [Related]

  • 10. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.
    Howard RJ, Pfaff WW, Brunson ME, Ramos EL, Peterson JC, Croker BP, Scornik JC, Parris CJ, Fennell RS.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):884. PubMed ID: 8442256
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression.
    Pallardó LM, Sánchez P, Sánchez J, García J, Beneyto I, Orero E, Rochera A.
    Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781
    [No Abstract] [Full Text] [Related]

  • 12. Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression.
    Francis DM, Walker RG, Millar RJ, Becker G.
    Transplant Proc; 1992 Oct; 24(5):1887-8. PubMed ID: 1412899
    [No Abstract] [Full Text] [Related]

  • 13. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N, Hong J, Miles A, Markell M, Distant D, Fleishhacker J, Maursky V, Jean-Baptiste F, Sommer B.
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract] [Full Text] [Related]

  • 14. Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants.
    Carmellini M, Romagnoli J, Pietrabissa A, Di Stefano R, Oleggini M, Rindi P, Rizzo G, Mosca F.
    Transplant Proc; 1994 Oct; 26(5):2546-7. PubMed ID: 7940785
    [No Abstract] [Full Text] [Related]

  • 15. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C, Almond PS, Payne WD, Dunn DL, Gores PF, Gruessner RW, Sutherland DE, Matas AJ, Najarian JS.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract] [Full Text] [Related]

  • 16. Cytokine-release syndrome: differences between high and low doses of OKT3.
    Norman DJ, Kimball JA, Barry JM.
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):35-8. PubMed ID: 8465420
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA, Shakuntala V, Dhawan IK, Zahir M, Shanwaz M, Hayes K, Pingle A.
    Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract] [Full Text] [Related]

  • 18. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA, Elbirk A, Rohr N, Jørgensen KA.
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO, Wheatley T, Feehally J, Nicholson ML, Veitch PS, Bell PR.
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract] [Full Text] [Related]

  • 20. Infections after renal transplantation.
    Ko KS, Cho DO, Ahn JH, Lee TW, Ihm CG, Chang SG, Chai SE, Park HC, Hong SH, Joo HZ.
    Transplant Proc; 1994 Aug; 26(4):2072-4. PubMed ID: 8066674
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.